Latest Circassia Stories
OXFORD, England, April 19, 2011 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has closed a GBP60 million ($98 million) fundraising.
NEW YORK, May 22 /PRNewswire/ -- The Circassian Cultural Institute issued the following statement today to commemorate the 145th anniversary of the Circassian Genocide: On Thursday the 21st of May, we commemorate the 145th Anniversary of the Circassian Genocide and pay tribute to the victims and survivors.
Circassia, a specialty biopharmaceutical company, has started a further Phase II clinical study of its ToleroMune technology in the field of cat allergy.
Circassia, a specialty biopharmaceutical company, has announced positive results from a Phase II clinical study of its anti-allergy technology, ToleroMune, in the field of cat allergy.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.